242 related articles for article (PubMed ID: 2496978)
21. Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides.
Riendeau D; Falgueyret JP; Nathaniel DJ; Rokach J; Ueda N; Yamamoto S
Biochem Pharmacol; 1989 Jul; 38(14):2313-21. PubMed ID: 2502118
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of 5-lipoxygenase metabolism by human neutrophils using a combination of activators.
Maclouf J; Iliou JP; Del Maschio A
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):105-8. PubMed ID: 3020579
[TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids.
Lee TH; Austen KF
Adv Immunol; 1986; 39():145-75. PubMed ID: 3098061
[No Abstract] [Full Text] [Related]
24. Soybean lipoxygenase-catalyzed formation of lipoxin A and lipoxin B isomers from arachidonic acid via 5,15-dihydroperoxyeicosatetraenoic acid.
Sok DE; Phi TS; Jung CH; Chung YS; Kang JB
Biochem Biophys Res Commun; 1988 Jun; 153(2):840-7. PubMed ID: 3132921
[TBL] [Abstract][Full Text] [Related]
25. Lipoxin syntheses by arachidonate 12- and 5-lipoxygenases purified from porcine leukocytes.
Yamamoto S; Ueda N; Yokoyama C; Fitzsimmons BJ; Rokach J; Oates JA; Brash AR
Adv Exp Med Biol; 1988; 229():15-26. PubMed ID: 3421157
[No Abstract] [Full Text] [Related]
26. Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase.
Imai H; Narashima K; Arai M; Sakamoto H; Chiba N; Nakagawa Y
J Biol Chem; 1998 Jan; 273(4):1990-7. PubMed ID: 9442035
[TBL] [Abstract][Full Text] [Related]
27. Role of the 15-lipoxygenase in the immune system.
Vanderhoek JY
Ann N Y Acad Sci; 1988; 524():240-51. PubMed ID: 3132881
[TBL] [Abstract][Full Text] [Related]
28. Kinetic effects of ATP and two cellular stimulatory components on human leukocyte 5-lipoxygenase.
Rouzer CA; Thornberry NA; Bull HG
Ann N Y Acad Sci; 1988; 524():1-11. PubMed ID: 3382136
[No Abstract] [Full Text] [Related]
29. Role of 5-lipoxygenase (5-LO) metabolites in ACTH-stimulated steroidogenesis.
Tamura Y; Hirai A; Tahara K; Terano T; Yoshida S
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():704-7. PubMed ID: 2823567
[No Abstract] [Full Text] [Related]
30. Intracellular cold trapping of exogenous arachidonic acid and activation of the 5-lipoxygenase pathway of human neutrophils.
Green FA
Inflammation; 1988 Feb; 12(1):45-50. PubMed ID: 2835319
[TBL] [Abstract][Full Text] [Related]
31. The regulation of 5-lipoxygenase activity in rat basophilic leukemia cells.
Wong A; Hwang SM; Cook MN
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():28-34. PubMed ID: 2169181
[No Abstract] [Full Text] [Related]
32. Lipoxin synthesis by arachidonate 12-lipoxygenase purified from porcine leukocytes.
Ueda N; Yokoyama C; Yamamoto S; Fitzsimmons BJ; Rokach J; Oates JA; Brash AR
Biochem Biophys Res Commun; 1987 Dec; 149(3):1063-9. PubMed ID: 3122743
[TBL] [Abstract][Full Text] [Related]
33. The involvement of extracellular calcium in the formation of 5-lipoxygenase metabolites by human polymorphonuclear leukocytes.
Schatz-Munding M; Hatzelmann A; Ullrich V
Eur J Biochem; 1991 Apr; 197(2):487-93. PubMed ID: 1902789
[TBL] [Abstract][Full Text] [Related]
34. 5-Lipoxygenase and leukotriene synthesis: effects of calcium ions and of inhibitors.
Reynolds CH
Prostaglandins; 1988 Jul; 36(1):59-68. PubMed ID: 2845484
[TBL] [Abstract][Full Text] [Related]
35. The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: structure-activity relationship and mechanism of action.
Petrich K; Ludwig P; Kühn H; Schewe T
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):911-6. PubMed ID: 8615788
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion.
Peters-Golden M; Shelly C
J Immunol; 1988 Mar; 140(6):1958-66. PubMed ID: 3126237
[TBL] [Abstract][Full Text] [Related]
37. Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity.
Werz O; Szellas D; Henseler M; Steinhilber D
Mol Pharmacol; 1998 Aug; 54(2):445-51. PubMed ID: 9687587
[TBL] [Abstract][Full Text] [Related]
38. MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.
Rouzer CA; Ford-Hutchinson AW; Morton HE; Gillard JW
J Biol Chem; 1990 Jan; 265(3):1436-42. PubMed ID: 2104841
[TBL] [Abstract][Full Text] [Related]
39. 5-Hydroxyeicosanoids selectively stimulate the human neutrophil 15-lipoxygenase to use endogenous substrate.
Nichols RC; Vanderhoek JY
J Exp Med; 1990 Feb; 171(2):367-75. PubMed ID: 2154526
[TBL] [Abstract][Full Text] [Related]
40. Platelet hypersensitivity induced by 1-chloro-2, 4-dinitrobenzene, hydroperoxides and inhibition of lipoxygenase.
Hill TD; White JG; Rao GH
Thromb Res; 1989 Mar; 53(5):447-55. PubMed ID: 2499941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
